Maravai LifeSciences Announces August 2023 Investor Conference Schedule
09 Agosto 2023 - 5:15PM
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of
life science reagents and services to researchers and biotech
innovators, is scheduled to participate in the following investor
conference during the month of August.
On August 16, 2023, at 2:00 p.m. PDT, Trey Martin, Chief
Executive Officer, and Kevin Herde, Chief Financial Officer, will
participate in a fireside chat at the UBS MedTech, Tools, and
Genomics Summit 2023, being held at the Waldorf Astoria Monarch
Beach Resort & Club in Dana Point, California.
A live webcast of the presentation will be available to all
interested parties on the Maravai LifeSciences Investor Relations
website, under News & Events. An archived version of the
webcast will also be available on the Maravai website following the
completion of the event.
About Maravai
Maravai is a leading life sciences company providing critical
products to enable the development of drug therapies, diagnostics,
and novel vaccines and to support research on human diseases.
Maravai’s companies are leaders in providing products and services
in the fields of nucleic acid synthesis and biologics safety
testing to many of the world’s leading biopharmaceutical, vaccine,
diagnostics, and cell and gene therapies companies.
For more information about Maravai LifeSciences, visit
www.maravai.com.
Contact Information:
Investor Contact:
Deb Hart
Maravai LifeSciences
+1 858-988-5917
ir@maravai.com
Media Contact:
Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macdougall.bio
Maravai LifeSciences (NASDAQ:MRVI)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Maravai LifeSciences (NASDAQ:MRVI)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024